Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Cethromycin, trade name Restanza (initially known as ABT-773) is a ketolide antibiotic undergoing research for the treatment of community acquired pneumonia (CAP) and for the prevention of post-exposure inhalational anthrax, and was given an "orphan drug" status for this indication. Originally discovered and developed by Abbott, it was acquired by…
Measurement & Overview
Explore the main themes, entities and connections around Cethromycin. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
acquired drug community pneumonia advanced life sciences fda new treatment 2008 application committee name status administration phase clinical ketolide abt-773
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Cethromycin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Cethromycin | ATC code | none | 1.00 | infobox |
| Cethromycin | Bioavailability | Between 35.8 and 60% in animal studies. | 1.00 | infobox |
| Cethromycin | CAS Number | 205110-48-1 Y | 1.00 | infobox |
| Cethromycin | ChEBI | CHEBI:29506 | 1.00 | infobox |
| Cethromycin | ChEMBL | ChEMBL365528 N | 1.00 | infobox |
| Cethromycin | ChemSpider | 23258189 N | 1.00 | infobox |
| Cethromycin | Elimination half-life | 1.6, 3.0, 4.5, 5.9 and 6 hours. Mouse, Monkey, Rat, Dog and Human respectively. | 1.00 | infobox |
| Cethromycin | Excretion | 7.0% urine 87.2% faeces | 1.00 | infobox |
| Cethromycin | Formula | C42H59N3O10 | 1.00 | infobox |
| Cethromycin | KEGG | D02391 N | 1.00 | infobox |
| Cethromycin | Legal status | US: Phase III Clinical Trials | 1.00 | infobox |
| Cethromycin | Melting point | 211 to 213 °C (412 to 415 °F) | 1.00 | infobox |
| Cethromycin | Metabolism | Liver | 1.00 | infobox |
| Cethromycin | Molar mass | 765.945 g·mol−1 | 1.00 | infobox |
| Cethromycin | PubChem CID | 5282045 | 1.00 | infobox |
| Cethromycin | Routes of administration | Oral | 1.00 | infobox |
| Cethromycin | UNII | J0086219X6 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.